This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
payments: Archive
V Gains Loyalty Edge as Collinson & On-us Unlock 1,800+ Airport Perks
by Zacks Equity Research
Visa expands its travel appeal as Collinson and On-us unlock instant access to 1,800+ lounges for eligible cardholders.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
business-services fin-tech finance payments travel-leisure
First Financial Bancorp (FFBC) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
FFBCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Global Payments Sinks 28.3% YTD: Dip Worth Buying or Just Dead Weight?
by Kaibalya Pravo Dey
GPN's steep YTD slide contrasts with its bold Worldpay deal and solid cash strength, raising questions about what's next for the payments player.
FISPositive Net Change FISVPositive Net Change GPNPositive Net Change
business-services fin-tech finance payments
Mastercard Turns on the Cash Tap: Buybacks Boom, Dividends Bloom
by Kaibalya Pravo Dey
MA boosts shareholder rewards with a new $14B buyback and a 14% dividend hike as strong cash flow fuels continued capital returns.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
business-services finance payments
Can Visa's Cross-Border Engine Still Deliver Double-Digit Growth?
by Zacks Equity Research
V's cross-border business surges with 11% volume growth, fueled by travel, e-commerce and new multi-currency and stablecoin features.
MAPositive Net Change VPositive Net Change PYPLPositive Net Change
business-services fin-tech finance payments
Should You Buy Alpine Income (PINE) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PINENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Leverage on the Rocks: Can Gen Z & Millennials Keep AmEx Premium?
by Kaibalya Pravo Dey
AXP leans on leverage and rising Gen Z and Millennial adoption to fuel returns while preserving its premium edge.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
finance payments
Market Loves Affirm at 54.6X Premium Valuation: But is Love Blind?
by Kaibalya Pravo Dey
AFRM's rich valuation towers over BNPL rivals as analysts still see upside, raising questions about how much growth is already priced in.
PYPLPositive Net Change AFRMNegative Net Change XYZPositive Net Change KLARPositive Net Change
fin-tech finance payments
The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PNTGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ATNIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TGSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Si-Bone (SIBN) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SIBNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
How Is Affirm Threading BNPL Growth Through Pacsun's Holiday Cart?
by Kaibalya Pravo Dey
AFRM taps Pacsun's holiday rush with new pay-over-time options, aiming to lift volume as young shoppers embrace BNPL.
PYPLPositive Net Change AFRMNegative Net Change XYZPositive Net Change
fin-tech finance payments
AmEx Trading Above 21X P/E: Playing Offense With a Higher Price Tag?
by Rajshree Sipani
AXP's premium valuation, strong revenue gains and surging Gen Z and Millennial spending put the stock at a pivotal moment.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
artificial-intelligence fin-tech finance payments
Visa at 25X Earnings: A Premium Story or a Better Buy on the Pullback?
by Kaibalya Pravo Dey
V's pullback and 25X earnings multiple raise the question: Does the stock's growth runway still justify its premium?
MAPositive Net Change VPositive Net Change AXPPositive Net Change
business-services finance payments
Can AXP Keep Its ROE Shining While Expenses Climb the Ladder?
by Zacks Equity Research
American Express navigates rising expenses with innovation and strong execution as it works to keep its standout ROE on track.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
artificial-intelligence fin-tech finance payments
After Golden Cross, Assured Guaranty (AGO)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AGOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Affirm's Low-Ticket Purchases Outgrow Its Big-Ticket Categories?
by Zacks Equity Research
AFRM shifts focus to everyday low-ticket purchases, boosting transactions, loyalty and platform growth beyond big-ticket items.
VPositive Net Change AFRMNegative Net Change KLARPositive Net Change
artificial-intelligence computers fin-tech payments
Does Visa's AWS Move Signal a New Standard for Secure AI Transactions?
by Zacks Equity Research
V's AWS partnership brings secure, tokenized tools and blueprints to power scalable agentic commerce and real-time autonomous transactions.
MAPositive Net Change VPositive Net Change AFRMNegative Net Change
artificial-intelligence business-services fin-tech finance payments
In-Store Tap: Klarna Plants Its Flag in 14 European Markets
by Kaibalya Pravo Dey
KLAR expands Tap to Pay across 14 European markets, building on the rapid global traction of the debit-first Klarna Card.
PYPLPositive Net Change AFRMNegative Net Change KLARPositive Net Change
business-services fin-tech finance payments
Tap, Travel, Transact: Is Visa Quietly Crafting the Perfect Growth Mix?
by Zacks Equity Research
V's tap-to-pay surge, cross-border rebound and AI-driven fraud tools are powering a potent growth mix for FY26.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
artificial-intelligence business-services fin-tech finance payments
Business First (BFST) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BFSTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Telecom Argentina (TEO) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
TEONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Why Is Gen Z Emerging as AmEx's Next Premium Growth Driver?
by Rajshree Sipani
AXP taps Gen Z and Millennials as demand for premium, experience-driven perks surges, turning young spenders into a powerful growth engine.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
fin-tech finance payments
Mastercard's Stability Vs. Affirm's Velocity: Which Has More Upside?
by Rajshree Sipani
AFRM's BNPL-driven surge puts it ahead, while MA's global scale reach keeps it firmly in the race as flexible credit rapidly reshapes spending.
MAPositive Net Change AFRMNegative Net Change
artificial-intelligence business-services e-commerce fin-tech payments software